Top Markets
Coin of the day
OptiNose, Inc. OptiNose, Inc.

OptiNose, Inc.

OPTN
Rang în acțiuni #9145
OptiNose, Inc. is a specialized pharmaceutical company primarily focused on... OptiNose, Inc. is a specialized pharmaceutical company primarily focused on innovating and bringing to market treatments for individuals under the care of ear, nose, throat, and allergy specialists throughout the United States. Its flagship product, XHANCE, utilizes the company's proprietary exhalation delivery system (EDS) to administer a topically-acting corticosteroid. This therapy is approved for treating chronic rhinosinusitis when accompanied by nasal polyps and is currently undergoing Phase IIIb clinical trials for broader chronic sinusitis treatment. The company also offers Onzetra Xsail, a powder-based EDS device, which is commercialized via a licensing agreement with Currax Pharmaceuticals LLC. Further expanding its pipeline, OptiNose is developing OPN-019, an investigational product that integrates a liquid EDS device with an antiseptic agent. Additionally, OptiNose has formed a partnership with Inexia Limited. This collaboration centers on the development, manufacturing, importation, and sale of products containing orexin receptor agonist or positive modulator molecules, intended for the treatment, diagnosis, or prevention of human conditions predominantly linked to orexin receptor activity. Established in 2000, OptiNose, Inc. operates from its corporate headquarters in Yardley, Pennsylvania.
Preț acțiune
$9.60
Ultima sincronizare: 2025-05-21
Capitalizare de piață
$1.08B
Schimbare (1 zi)
0.00%
Schimbare (1 an)
0.00%
Țară
US
Tranzacționează OptiNose, Inc. (OPTN)

Categorie

Raport P/B pentru OptiNose, Inc. (OPTN)
Raport P/B la data de August 2026 TTM: -2.42
Conform celor mai recente rapoarte financiare și prețului acțiunilor OptiNose, Inc., raportul P/B actual (TTM) este -2.42. La sfârșitul anului 2023, compania avea un P/B de -25.04.
Istoricul raportului P/B pentru OptiNose, Inc. din 2015 până în 2026
Raport P/B la sfârșitul fiecărui an
An Raport P/B Schimbă
2026 (TTM) -2.42 43.80%
2024 -1.68 -93.29%
2023 -25.04 792.27%
2022 -2.81 -95.58%
2021 -63.45 -114.37%
2020 441.64 369.60%
2019 94.05 201.63%
2018 31.18 -49.24%
2017 61.42 -130.42%
2016 -201.90 -28.02%
2015 -280.48 0.00%
Raport P/B pentru companii similare sau competitoare